Virginia International Raceway has acquired full ownership of the land it operates on, ending a decades-long lease and ...

Vir Biotechnology is handing off certain commercial rights for its hepatitis D program to European specialty pharma Norgine ...

VIRginia International Raceway announced today that it has officially acquired full ownership of the land that the historic ...

Vir Biotechnology plans to give an exclusive license for the commercial rights to a chronic hepatitis delta treatment to an affiliate of Norgine. The biopharmaceutical company said Tuesday the license ...

Many racetracks have succumbed to high real-estate prices in recent years, their sweeping turns or steep banking replaced by subdivisions or warehouses. At least for now, Virginia International ...

ALTON, Va. (WFXR) – The VIRginia International Raceway (VIR) has announced this year is its 25th anniversary and is gearing up to celebrate with high-octane heart-pumping thrills all season.

Agreement underscores Norgine's mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceuticals. -- Vir Biotechnology's chronic hepatitis delta ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the efficacy results hoped for in a midstage study. The investigational combo of ...

- Phase 3 ECLIPSE registrational clinical program in chronic hepatitis delta on track to begin in the first half of 2025 - Tobevibart and elebsiran in chronic hepatitis delta received U.S. FDA ...